October 11, 2013

Glucocorticoid Dose Thresholds Associated With All‐Cause and Cardiovascular Mortality in Rheumatoid Arthritis

Key Points

Key points are not available for this paper at this time.

Abstract

Glucocorticoid use in RA is associated with a dose-dependent increase in mortality rates, with a daily threshold dose of 8 mg, at which the number of deaths increased in a dose-dependent manner. These findings may assist clinicians in selecting the appropriate glucocorticoid dosage for RA patients who require these agents.

Bookmark

Cite This Study

Rincón et al. (Fri,) studied this question.

synapsesocial.com/papers/69d90134f544bba627bedce4 https://doi.org/https://doi.org/10.1002/art.38210

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Duke severity of illness checklist (DUSOI) for measurement of severity and comorbidity1993 · 174 citations
2Survival, prognosis, and causes of death in rheumatoid arthritis1986 · 439 citations
3Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.1997 · 420 citations
4The Socioeconomic Approach to Status Measurement, with a Guide to Occupational and Socioeconomic Status Scores.1985 · 67 citations
5Proportional hazards tests and diagnostics based on weighted residuals1994 · 5,601 citations

Bookmark